AXON
AXON ENTERPRISE, INC.Evidence as of 2026-10-01The desk's Snapshot
3 of 15 open to everyone · members see allRead the full desk report on AXON
Seven analysts, the debate, the risk review, every claim cited. And the same for every name you hold.
Free plan, no credit card required. Silver opens the full report, $19.99 a month. AI-written · every claim cites a source · Insight, not advice.
Overview · AXON ENTERPRISE, INC.
Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products inc…
Management team
- Mr. Ran Mokady · Senior VP of Real-Time Operations & Site GMFind on LinkedIn
- Mr. Josh Goldman · Executive Vice President of OperationsFind on LinkedIn
- Ms. Elizabeth Hart · Executive Vice President of People OperationsFind on LinkedIn
- Ms. Abigail Stock B.A. · Executive Vice President of MarketingFind on LinkedIn
Start free to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
Moneyta sentiment
Where the published evidence leans after the desk debated it, not a rating or a recommendation.
−0.7 on a −2 to +2 scale.
What builds the score
Solid bars are analyst rubric scores; faded bars are computed directly from data. Claims dropped in debate count for nothing; weakened claims count at half weight.
Editor's note
Written after the debate settled. The rest of the page is the evidence behind it.
The evidence balance is Cautious ( -0.7 of a possible +2; confidence high). Revenue and gross profit rose steadily across the reported sequence: revenue from USD 668,538,000 for the quarter 2025-04-01 to 2025-06-30 (3mo) to USD 710,641,000 for 2025-07-01 to 2025-09-30 (3mo), then USD 807,345,000 for 2026-01-01 to 2026-03-31 (3mo) and USD 904,389,000 for 2026-04-01 to 2026-06-30 (3mo). Gross profit grew in step, reaching USD 546,447,000 in the 2026-04-01 to 2026-06-30 (3mo) period and producing a gross margin of about 60.4% for that quarter.
At the same time, net income and diluted EPS fell from net income USD 169,312,000 / diluted EPS USD 2.05 in the 2026-01-01 to 2026-03-31 (3mo) period to net income USD 29,427,000 / diluted EPS USD 0.36 in the 2026-04-01 to 2026-06-30 (3mo) period. Free cash flow for the trailing twelve months was negative USD 150,678,000 and FCF per share was - USD 1.8255, while TTM operating cash flow was negative USD 77,984,000 with capital expenditures of USD 72,694,000. Leverage on a point-in-time basis moved lower as reported long-term debt decreased from about USD 2,008,926,000 as of 2025-09-30 to USD 1,731,817,000 as of 2026-06-30, while common shares outstanding increased to 81,237,415 as of 2026-07-31.
How this note was made
every stage ran before the note was writtenAnalyst desk
Mercer, Oakes, Nash, Ellis, Yates, Talbot and Archer. The desk: named AI agents, not people. Each reads one slice of the evidence and nothing else (no outside knowledge, no browsing), so every finding traces to a source you can open.
Reads the XBRL figures companies file with the SEC (revenue, margins, income, debt and share count, quarter by quarter) and reports which way the trend is running.
Revenue rose across the reported sequence: USD 668,538,000 in the quarter 2025-04-01 to 2025-06-30 (3mo) to USD 710,641,000 in the quarter 2025-07-01 to 2025-09-30 (3mo), then to USD 807,345,000 in the quarter 2026-01-01 to 2026-03-31 (3mo) and to USD 904,389,000 in the quarter 2026-04-01 to 2026-06-30 (3mo).
XBRL companyfacts · 0001628280-26-053646Gross profit increased in the same periods: USD 403,743,000 in 2025-04-01 to 2025-06-30 (3mo) to USD 427,348,000 in 2025-07-01 to 2025-09-30 (3mo), then USD 477,286,000 in the quarter 2026-01-01 to 2026-03-31 (3mo) and USD 546,447,000 in the quarter 2026-04-01 to 2026-06-30 (3mo).
XBRL companyfacts · 0001628280-26-053646Reads the filings themselves, above all the year-over-year diff of Item 1A risk factors: which risks a company added, dropped or quietly reworded since its last annual report.
Which filings the desk reads
The desk reads the annual 10-K in full: its risk factors, and how they changed since last year. Quarterly 10-Qs and event filings (8-Ks, insider Form 4s) are listed for context but not read line by line: the 10-K is where the material risk disclosures live. A brand-new company, or one we have only just begun tracking, may have no annual report on file yet; its risk analysis fills in once that lands.
In the Annual Report on Form 10-K filed 25 February 2026, the company states it "substantially depend[s] on continued acceptance of our products and services by law enforcement agencies worldwide, and any reduction in demand could materially adversely affect our business."
10-K filed 2026-02-25The 10-K filed 25 February 2026 expressly warns that "Failure to comply with federal, state, or local regulations applicable to our firearm product, the TASER 10 CED, could result in governmental actions or litigation, potentially harming our business prospects, operating results and financial condition."
10-K filed 2026-02-25Reads the signal panel above (momentum, volatility, drawdown, relative strength and beta) and ranks each against the whole research universe rather than judging it in isolation.
No computed signal history for this symbol yet — signals need roughly 70 trading days of price history.
Reads which funds hold the name and at what weight, plus insider Form 4 filings, to show the exposure you may already carry through index funds.
13F-reported institutional holdings total $41.23B as of 2026-06-30, with 1,139 institutional holders reported and a quarter-over-quarter reported value change of 25.7%.
13F holdings · 1139 filers · as of 2026-06-30Top reported institutional holders in the 13F data as of 2026-06-30 include BlackRock, Inc. at $4.67B, VANGUARD CAPITAL MANAGEMENT LLC at $2.88B, and STATE STREET CORP at $2.18B.
13F holdings · 1139 filers · as of 2026-06-30Reads recent headlines that are genuinely about this company, ignoring rating chatter and market-wide stories. Findings argue in the debate but never move the sentiment score.
An article on 30 September 2026 reports Axon Enterprise announced raised guidance alongside its quarterly results, describing the guidance as pointing to substantial revenue growth.
News · kalkinemedia.com · 2026-09-30Coverage on 28 September 2026 notes Axon completed a US$1 billion offering of zero-coupon convertible notes due September 2031 and frames the instrument as sitting between equity and traditional debt.
News · simplywall.st · 2026-09-28Reads parsed Forms 3/4/5: who bought or sold, at what size, and whether a 10b5-1 plan was involved. Flags clustered open-market officer buying; treats plan sales as routine and never counts a fund or 10%-holder as an officer.
Patrick W. Smith (Chief Executive Officer) reported multiple open-market sales on 8 September 2026 totaling 10,000 shares for $5,091,000 under a stated 10b5-1 trading plan (11 separate sale line items on that filing).
Form 4 · SMITH PATRICK W (CHIEF EXECUTIVE OFFICER) · $36k sold · 2026-09-08Isaiah Fields (Chief Legal Officer) reported a sale of 1,017 shares for $489,000 on 11 September 2026 and identified the trade as occurring under a 10b5-1 plan on the filing.
Form 4 · Fields Isaiah (Chief Legal Officer) · $489k sold · 2026-09-11Reads the implied-expectations math built from the company's own filings (the growth rate today's price would justify, and the multiples beside it) and argues whether the market's bar looks high or low for this business. Never turns the math into a target.
Free cash flow for the trailing twelve months was negative $150,678,000 and free cash flow per share was -$1.8255.
Valuation inputs · SEC XBRL + stored EOD closeNet cash provided by/used in operating activities for the trailing twelve months was negative $77,984,000 while capital expenditures were $72,694,000 for the same period.
Valuation inputs · SEC XBRL + stored EOD closeDebate and risk review
A bull and a bear contest the claims and the chair rules on each; the risk review stress-tests what survived.
A bull and a bear argue the analysts' claims across two rounds, then a chair rules on each one. Only what survives feeds the score. The argument is shown, not hidden, so you can judge the reasoning yourself.
The company-reported quarterly sequence shows consistent top-line growth and expanding gross profit and margin across the cited reporting periods (fundamentals-0, fundamentals-1, fundamentals-2), and point-in-time long-term debt declined over the same window (fundamentals-5). Large reported institutional holdings and named top holders (ownership-0, ownership-1) plus multiple buy-side analyst actions and late-September coverage (news-5, news-0, news-1) together provide corroborating market interest. While trailing profitability and cash-flow metrics are weak on a TTM basis (valuation-0, valuation-1, valuation-3) and the 10‑K discloses past restatements and a material weakness (filings-3), the direct company filings and 13F data constitute strong primary evidence for the improving revenue/gross-profit trend and reduced long-term debt. Financial advisors often point out that rising revenue and gross margin, combined with reduced leverage and meaningful institutional ownership, are elements market participants interpret as supportive of a favorable operational read, even when trailing valuation multiples appear elevated.
Chair's verdict, claim by claim
Fragility · computed, not argued
balanced0.31
32 surviving claims rest on 16 distinct sources; the heaviest analyst carries 19% of them, and 100% of what the desk raised survived the debate.
The set of 32 surviving claims is supported by a moderate breadth of sources (16 distinct ones), so many individual statements are corroborated across filings and press coverage. However, one analyst contributing nearly a fifth of the claims and the fact that everything the desk raised survived debate suggest persistent internal confirmation rather than aggressive falsification; treat the aggregate read as informative but moderately fragile when used to drive strong conclusions.
Disconfirming evidence · base rates · falsifiers
Context
Outside consensus, and where this name already sits in your own portfolio.
Third-party consensus shown for context. It never enters Moneyta sentiment. When the two diverge, the debate above is where the why lives.
What this was built from
Every figure on this page traces to one of these. The desk reads only what is listed here (no outside knowledge, no browsing), and each card shows who read it and what it contributed to the score.
11 filings· 2 cited
SEC XBRL filings
Quarterly figures as filed with the SEC, read straight from EDGAR's structured data, not retyped or estimated.
Read by Mercer+0.3 to the score
13 documents· 3 cited
SEC filing documents
The filings themselves, including the year-over-year comparison of Item 1A risk factors.
Read by Oakes−1.2 to the score
3 holdings records· 1 cited
Fund holdings
Which funds hold this name and at what weight, plus insider Form 4 filings.
Read by Ellis+0.2 to the score
8 headlines· 2 cited
News coverage
Recent headlines about this company, rating chatter excluded and nothing published after the report date.
Read by Yatesnothing survived
7 filings· 2 cited
Insider filings
Parsed Forms 3/4/5 from EDGAR: named insiders, share counts, prices, and 10b5-1 plan state, with stated and inferred flags kept apart.
Read by Talbot−0.8 to the score
1 computation
Valuation inputs
TTM cash-flow figures from the company's own XBRL filings, priced with the stored closing price. Implied growth and multiples only; no fair-value dollar figure reaches the desk, by design.
Read by Archercontext only
1 record· 0 cited
Company profile
Sector, industry and company details.
1 record· 0 cited
Analyst consensus
Third-party consensus, shown for context only; it never enters Moneyta sentiment.
Read means we pulled and handed it to an analyst; cited means a claim on this page points at it. Reading twelve quarters to state one trend is normal; the gap is shown rather than hidden.
Written by AI, checked against sources
The analysts, the bull–bear debate and the editor's note are AI agents reading only the evidence listed on this page. They can misread a filing or a headline, which is why every claim cites a source you can open and check yourself. The sentiment score is arithmetic over the claims that survived the debate, not a language model's opinion.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations. Past patterns do not indicate future results.
The full terminal on AXON Gold
Who holds it, who's buying, what the Street thinks: live behind the lock, updated as filings land.
Institutional holders
Net institutional flow, Q/Q
Largest holder position
Insider buys, 90 days
Clustered insider value
Street target range
The real figures are for members. Educational analysis, not advice.
Get this for the names you actually hold
Every name in your portfolio, researched the same way, plus the one thing no sample can show: how each one sits inside what you already own.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations.